Aelis Farma S.A.
AELIS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €27 | €168 | €160 | €121 |
| - Cash | €14 | €20 | €34 | €25 |
| + Debt | €6 | €4 | €4 | €6 |
| Enterprise Value | €19 | €152 | €130 | €103 |
| Revenue | €3 | €9 | €4 | €9 |
| % Growth | -70.4% | 137.7% | -58% | – |
| Gross Profit | €3 | €9 | €4 | €9 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -€9 | -€6 | -€16 | €1 |
| % Margin | -321.8% | -70.1% | -426% | 9.3% |
| Net Income | -€7 | -€5 | -€14 | €1 |
| % Margin | -278.4% | -56.1% | -375.1% | 6.3% |
| EPS Diluted | -0.54 | -0.39 | -1.21 | 0.06 |
| % Growth | -38.5% | 67.8% | -2,123.4% | – |
| Operating Cash Flow | -€12 | -€13 | -€13 | €19 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€12 | -€13 | -€13 | €19 |